Psychological therapies for treatment-resistant depression in adults (Q24202603)

https://api.crossref.org/works/10.1002%2F14651858.CD010558

Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

Augmentation strategies for treatment-resistant depression: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

Augmentation strategies for treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

A systematic review of treatments for refractory depression in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

Diagnosis and definition of treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

Diagnostic Criteria for Use in Psychiatric Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

Imputing missing standard deviations in meta-analyses can provide accurate results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

Acceptance and commitment therapy: model, processes and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

Acceptance and mindfulness-based therapy: new wave or old hat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

Clinician's judgments of mental health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

A theory of human motivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

The effectiveness of psychological treatments for treatment-resistant depression: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

Secular trends in antidepressant prescribing in the UK, 1975-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

A critical overview of the pharmacologic management of treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

National patterns in antidepressant medication treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

Combined pharmacotherapy and psychological treatment for depression: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

Research diagnostic criteria: rationale and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

The World Health Organization quality of life assessment (WHOQOL): Development and general psychometric properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

7 January 2021

DBT, FAP, and ACT: How empirically oriented are the new behavior therapy technologies?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

7 January 2021

Cognitive-behavioral analysis system of psychotherapy: an interactional treatment approach for dysthymic disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

7 January 2021

Projections of global mortality and burden of disease from 2002 to 2030

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

7 January 2021

Recent trends in the use of antidepressant drugs in Australia, 1990-1998.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010558

7 January 2021